Avenue Therapeutics, Inc. Profile Avatar - Palmy Investing

Avenue Therapeutics, Inc.

Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in…

Biotechnology
US, New York [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Avenue Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Avenue Therapeutics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Avenue Therapeutics, Inc..

End of ATXI's Analysis
CIK: 1644963 CUSIP: 05360L205 ISIN: US05360L3042 LEI: - UEI: -
Secondary Listings
ATXI has no secondary listings inside our databases.